China Medical University Hospital, Hsinchu, in collaboration with the Hsinchu Science Park Bureau, recently hosted the Sustainability and Precision Health Achievement Showcase. The event invited prominent companies such as Purowang Biotechnology, AU Optronics, Caduceus Biotechnology Inc., Han Yuan Bio, and Hua Lian Biotechnology to present their research findings from the 2023 Precision Health Cross-Domain Promotion Project. A matchmaking zone was set up to facilitate collaborations between research teams and companies.
Caduceus Biotechnology Inc. showcased a novel multiplex molecular detection chip coupled with a microfluidic microarray imaging system. This innovative system requires only 1/10 to 1/100 of the blood sample volume compared to traditional methods for the accurate detection of neurodegenerative proteins. The underlying principle involves the use of microfluidic chips with micropores to amplify the fluorescent signals of target proteins, significantly enhancing detection sensitivity. The multiplex molecular detection system has completed design verification and is poised to enter clinical trials at medical centers.
Comments